Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia
Authors
Keywords
-
Journal
HEMATOLOGICAL ONCOLOGY
Volume 36, Issue 2, Pages 422-428
Publisher
Wiley
Online
2017-12-08
DOI
10.1002/hon.2488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Harmonemia: a universal strategy for flow cytometry immunophenotyping—A European LeukemiaNet WP10 study
- (2016) F Lacombe et al. LEUKEMIA
- Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
- (2016) María-Belén Vidriales et al. LEUKEMIA RESEARCH
- Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia
- (2015) Vinod Pullarkat et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact on Outcome in Acute Myeloid Leukemia
- (2015) Xueyan Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?
- (2014) D. Grimwade et al. BLOOD
- Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia
- (2014) K. Beldjord et al. BLOOD
- Establishment of harmonization in immunophenotyping: A comparative study of a standardized one-tube lymphocyte-screening panel
- (2014) F.W.M.B. Preijers et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Should evaluation for minimal residual disease be routine in acute myeloid leukemia?
- (2013) Elaine Coustan-Smith et al. CURRENT OPINION IN HEMATOLOGY
- Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study
- (2013) Françoise Solly et al. CYTOMETRY PART A
- Residual disease in AML, a target that can move in more than one direction
- (2013) Michael R. Loken CYTOMETRY PART B-CLINICAL CYTOMETRY
- Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group
- (2013) S. Bertoli et al. HAEMATOLOGICA
- High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
- (2013) Monique Terwijn et al. JOURNAL OF CLINICAL ONCOLOGY
- Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group
- (2012) M. R. Loken et al. BLOOD
- Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL
- (2012) R Garand et al. LEUKEMIA
- Array-Based Cytogenetic Approaches in Acute Myeloid Leukemia: Clinical Impact and Biological Insights
- (2012) Lars Bullinger et al. SEMINARS IN ONCOLOGY
- Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms
- (2011) Gert J. Ossenkoppele et al. BRITISH JOURNAL OF HAEMATOLOGY
- Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
- (2011) Alida Dominietto CURRENT OPINION IN HEMATOLOGY
- Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
- (2011) M C Béné et al. LEUKEMIA
- The role of multiparameter flow cytometry for disease monitoring in AML
- (2010) Wolfgang Kern et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Molecular diagnostics in acute leukemias
- (2009) Ulrike Bacher et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now